A groundbreaking FDA approval could change lives. New York-based Regeneron is offering the first gene therapy for genetic hearing loss at no cost to U.S. patients.
Hundreds of people gathered in Utica, Rome and Herkimer on Saturday as part of a nationwide “No Kings” protest movement that brought millions into the streets across the country and around the world.